KRAS 8 Mutations Detection Kit (Fluorescence PCR)

A real-time PCR diagnostic kit for KRAS mutation detection. Applied in solid tumour diagnostics for identifying KRAS gene mutations associated with various cancer types.

A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.

A molecular diagnostics reagent kit for human MTHFR gene typing using PCR with fluorescent probes. The kit enables genetic analysis for clinical and personalized medicine applications.

PCR-based fluorescence detection kit for identifying multi-gene methylation patterns in colorectal cancer screening and diagnosis. Enables risk stratification, early detection, treatment guidance, and post-operative monitoring through molecular analysis of epigenetic biomarkers.

Molecular diagnostic kit for detecting JAK2 V617F mutation in myeloproliferative neoplasms. Supports diagnosis of polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

A diagnostic kit for detecting IDH1 R132H mutations in glioma patient tissue samples. It achieves high sensitivity detecting mutations as low as 1% in 10ng/μL samples with specificity exceeding 99%. The results are provided with clear data output and objective interpretation without subjective judgment. It enables convenient operation allowing detection of 90 samples in a single run within 1 hour while maintaining a compact system design with minimal contamination risk.

Rapid PCR-based detection kit designed for quick identification of genetic markers and disease-related sequences. Suitable for urgent clinical diagnostic scenarios.

Polymerase chain reaction kits for molecular diagnosis and genetic analysis. Enables amplification and detection of specific DNA sequences.

A diagnostic kit for detecting TERT C228T and C250T promoter mutations in glioma patient tissue samples. It provides high sensitivity detecting mutations as low as 1% in 10ng/μL samples with specificity exceeding 99%. The kit delivers clear data output and objective interpretation without requiring subjective judgment. It supports convenient operation with capacity to test 90 samples in a single run within 1 hour using a compact system design minimizing contamination.

PCR-based detection kit for identifying cystic fibrosis transmembrane conductance regulator mutations in patient samples. Enables genetic screening for cystic fibrosis susceptibility and diagnosis.

Molecular detection kit for Candida krusei fungal species. Used for identification and infection diagnosis in clinical specimens.

PCR-based molecular diagnostic kit for genetic disease detection and identification. Utilizes polymerase chain reaction technology for accurate nucleic acid analysis.